Acura Pharmaceuticals, Inc. (NasdaqCM:ACUR - News) announced that Robert Jones, Chief Operating Officer, will present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th at 3:00 p.m. ET at the Waldorf Astoria in New York City.
A live audio webcast of the presentation will be available at http://www.wsw.com/webcast/nblr2/acur/. A replay of the webcast may be accessed for 30 days at the same website.
About Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) (abuse deterrent) Technology and related product candidates. For more information, please visit http://www.acurapharm.com.
The Acura Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4847
Contact:
Acura Pharmaceuticals, Inc.
Peter A. Clemens, SVP Investor Relations & CFO
847-705-7709
Source: Acura Pharmaceuticals, Inc.
A live audio webcast of the presentation will be available at http://www.wsw.com/webcast/nblr2/acur/. A replay of the webcast may be accessed for 30 days at the same website.
About Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) (abuse deterrent) Technology and related product candidates. For more information, please visit http://www.acurapharm.com.
The Acura Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4847
Contact:
Acura Pharmaceuticals, Inc.
Peter A. Clemens, SVP Investor Relations & CFO
847-705-7709
Source: Acura Pharmaceuticals, Inc.
0 comments:
Post a Comment